Cognito Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
55 Cambridge Pkwy Ste 102W, Cambridge, M...Phone Number
(857) 201-5088Website
www.cognitotx.comRevenue
$10.6 MillionIndustry
About Cognito Therapeutics
Cognito Therapeutics is focused on developing disease-modifying treatments aimed at improving the health and well-being of patients with Alzheimer's disease. Their investigational platform, Spectris, utilizes non-invasive audiovisual stimulation to evoke specific brain wave activity, potentially preserving brain structure, cognition, and function. The company has shown promising results in clinical studies, demonstrating the ability to slow cognitive decline and preserve brain volume in treated patients. Cognito is also exploring treatments for other neurodegenerative diseases and has received FDA Breakthrough Device Designation for their innovative approach.Explore more
Cognito Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cognito Therapeutics
Compare insights from companies similar to Cognito Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cognito Therapeutics Tech Stack
A closer look at the technologies used by Cognito Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cognito Therapeutics
Sign Up For FreeTo access detailed company insights
Cognito Therapeutics is focused on developing disease-modifying treatments aimed at improving the health and well-being of patients with Alzheimer's disease. Their investigational platform, Spectris, utilizes non-invasive audiovisual stimulation to evoke specific brain wave activity, potentially preserving brain structure, cognition, and function.... Read More
